SOURCE: ONE Bio, Corp.

June 18, 2010 08:00 ET

ONE Bio Signs Supermarket Chains Expanding Its Organic Vegetable Business

MIAMI, FL--(Marketwire - June 18, 2010) -  ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its subsidiary, United Green Technology, Inc. ("UGTI") through its Chinese operating unit, signed two distribution agreements with supermarket chains for distributing its organic vegetable and fruits products.

ONE's organic products division has just signed new lucrative distribution agreements which will result in more rapid expansion into the retail environment in mainland China. Recently, ONE signed distribution agreements with two supermarket chains in order to offer retail distribution of our products in more than 20 locations. The first two supermarket chains that ONE has partnered with are located in the Fuijan province and operate stores under the Xin Huadu and Jie long brand names. These are established retailers in their respective markets.

"This development within our OP division is just the start of ONE embarking on many promising retail opportunities to come. We are seeing consumers in the targeted areas adopt our products extremely well," stated Jinrong Tang, Sr. Vice President (China). "We are currently in the process of aggressively expanding distribution channels across China. In the meantime, we already identified 14 other large market style chains with roughly 150 more locations as potential partners. ONE is also working to sign new agreements with retailers that have a global footprint and rich domestic experience on the mainland. These retailers include but are not limited to Carrefour, Metro, Wal-Mart and Yong Hui," added Tang.

"We've added 3 regional sales offices to support our expansion and added 4 senior sales directors. By November ONE is expected to have a total of 110 local sales associates in the areas targeted for expansion in order to handle the anticipated growth in volume," stated ONE's CEO Marius Silvasan. "Currently, market demand in China for high quality organic produce is approximately 2.5 billion Kg. per annum. We anticipate grabbing 0.044% in market share in 2010, which will in turn contribute $3 million to sales revenue and bring $1.95 million dollars in gross profit. Our growth strategy is based on the consistent introduction of new, innovative and high margin/high profit products," added Silvasan.

About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTCBB: ONBI) ( headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE's growth plan targets an aggressive acquisition driven strategy supported by strong organic growth. Through ONE, small private companies gain access to capital, experienced management and strategic insight. ONE builds strong synergies amongst all subsidiaries to enhance shareholder value. ONE is working with each subsidiary to promote organic and acquisition driven growth.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information